{
    "hands_on_practices": [
        {
            "introduction": "Understanding the impact of a disease begins with epidemiology. This practice demonstrates how to quantify the burden of Barrett esophagus in a population by integrating common risk factors. By using concepts like relative risk and prevalence, you will learn to calculate the absolute incidence, bridging the gap between individual risk profiles and public health outcomes .",
            "id": "4331401",
            "problem": "A pathologist is modeling how commonly Barrett esophagus is newly diagnosed in a large, stable hypothetical population during one year. The foundational epidemiologic facts available are:\n\n- The baseline annual incidence of Barrett esophagus among individuals with none of the listed risk factors is $2.0 \\times 10^{-3}$ per person-year.\n- Four independent risk factors are considered: male sex, central obesity, current cigarette smoking, and chronic Gastroesophageal Reflux Disease (GERD). Each risk factor multiplies the baseline incidence by its relative risk.\n- The relative risks are: male sex $RR_{\\text{male}} = 2.0$, central obesity $RR_{\\text{obesity}} = 1.8$, smoking $RR_{\\text{smoking}} = 1.3$, chronic GERD $RR_{\\text{GERD}} = 3.5$.\n- The prevalences of these risk factors in the population are: male sex $p_{\\text{male}} = 0.49$, central obesity $p_{\\text{obesity}} = 0.30$, smoking $p_{\\text{smoking}} = 0.20$, chronic GERD $p_{\\text{GERD}} = 0.10$.\n\nStarting from the definitions of absolute risk (incidence), relative risk, and the law of total probability, and assuming the joint effects of the risk factors are multiplicative and the risk factors are independent in this population, compute the expected absolute annual incidence of Barrett esophagus in this population by appropriately integrating over the distribution of risk factors.\n\nExpress the final incidence per person-year as a decimal and round your answer to four significant figures.",
            "solution": "The problem is deemed valid as it is scientifically grounded in epidemiological principles, well-posed, objective, and internally consistent.\n\nThe objective is to compute the expected absolute annual incidence of Barrett esophagus in a population, which we denote as $I_{total}$. This quantity is the average incidence rate across all individuals in the population, accounting for the distribution of risk factors. We will use the law of total expectation.\n\nLet $I_0$ be the baseline annual incidence for individuals with no risk factors. The problem states $I_0 = 2.0 \\times 10^{-3}$ per person-year.\n\nThere are $4$ independent risk factors. Let us define a set of Bernoulli random variables, $X_i$ for $i \\in \\{1, 2, 3, 4\\}$, where $X_i=1$ if an individual has the $i$-th risk factor and $X_i=0$ otherwise. The prevalences of these risk factors are the probabilities that $X_i=1$. Let's assign them as follows:\n- $X_1$: Male sex. The prevalence is $p_1 = P(X_1=1) = p_{\\text{male}} = 0.49$.\n- $X_2$: Central obesity. The prevalence is $p_2 = P(X_2=1) = p_{\\text{obesity}} = 0.30$.\n- $X_3$: Smoking. The prevalence is $p_3 = P(X_3=1) = p_{\\text{smoking}} = 0.20$.\n- $X_4$: Chronic GERD. The prevalence is $p_4 = P(X_4=1) = p_{\\text{GERD}} = 0.10$.\n\nThe corresponding probabilities of not having each risk factor are $P(X_i=0) = 1 - p_i$.\n- $P(X_1=0) = 1 - 0.49 = 0.51$\n- $P(X_2=0) = 1 - 0.30 = 0.70$\n- $P(X_3=0) = 1 - 0.20 = 0.80$\n- $P(X_4=0) = 1 - 0.10 = 0.90$\n\nThe relative risks ($RR$) associated with each factor are:\n- $RR_1 = RR_{\\text{male}} = 2.0$\n- $RR_2 = RR_{\\text{obesity}} = 1.8$\n- $RR_3 = RR_{\\text{smoking}} = 1.3$\n- $RR_4 = RR_{\\text{GERD}} = 3.5$\n\nThe problem states that the joint effects of the risk factors are multiplicative. The incidence $I$ for an individual with a specific combination of risk factors, represented by the vector of outcomes $(x_1, x_2, x_3, x_4)$ for $(X_1, X_2, X_3, X_4)$, is given by:\n$$I(x_1, x_2, x_3, x_4) = I_0 \\cdot (RR_1)^{x_1} \\cdot (RR_2)^{x_2} \\cdot (RR_3)^{x_3} \\cdot (RR_4)^{x_4}$$\nThis formulation correctly captures the multiplicative effect: if a risk factor is present ($x_i=1$), the incidence is multiplied by $RR_i$; if it is absent ($x_i=0$), the multiplier is $(RR_i)^0 = 1$.\n\nThe expected absolute annual incidence for the entire population, $I_{total}$, is the expectation of the random variable $I(X_1, X_2, X_3, X_4)$:\n$$I_{total} = E[I] = E[I_0 \\cdot RR_1^{X_1} \\cdot RR_2^{X_2} \\cdot RR_3^{X_3} \\cdot RR_4^{X_4}]$$\nSince $I_0$ is a constant, it can be factored out of the expectation:\n$$I_{total} = I_0 \\cdot E[RR_1^{X_1} \\cdot RR_2^{X_2} \\cdot RR_3^{X_3} \\cdot RR_4^{X_4}]$$\nThe problem states that the risk factors are independent. For independent random variables, the expectation of a product is the product of a expectations. Therefore:\n$$I_{total} = I_0 \\cdot E[RR_1^{X_1}] \\cdot E[RR_2^{X_2}] \\cdot E[RR_3^{X_3}] \\cdot E[RR_4^{X_4}]$$\nThis crucial step is a direct consequence of the independence assumption.\n\nNow, we must compute the expectation for each term $E[RR_i^{X_i}]$. For a Bernoulli random variable $X_i$, the expectation of a function $g(X_i)$ is $g(0)P(X_i=0) + g(1)P(X_i=1)$. Here, $g(X_i) = RR_i^{X_i}$.\n$$E[RR_i^{X_i}] = (RR_i)^0 \\cdot P(X_i=0) + (RR_i)^1 \\cdot P(X_i=1)$$\n$$E[RR_i^{X_i}] = 1 \\cdot (1 - p_i) + RR_i \\cdot p_i = 1 - p_i + p_i \\cdot RR_i = 1 + p_i(RR_i - 1)$$\nThis term represents the average risk multiplier for factor $i$ across the population. Let's calculate this for each of the $4$ risk factors.\n\nFor male sex ($i=1$):\n$$\\overline{RR_1} = E[RR_1^{X_1}] = 1 + p_1(RR_1 - 1) = 1 + 0.49(2.0 - 1.0) = 1 + 0.49(1.0) = 1.49$$\n\nFor central obesity ($i=2$):\n$$\\overline{RR_2} = E[RR_2^{X_2}] = 1 + p_2(RR_2 - 1) = 1 + 0.30(1.8 - 1.0) = 1 + 0.30(0.8) = 1 + 0.24 = 1.24$$\n\nFor smoking ($i=3$):\n$$\\overline{RR_3} = E[RR_3^{X_3}] = 1 + p_3(RR_3 - 1) = 1 + 0.20(1.3 - 1.0) = 1 + 0.20(0.3) = 1 + 0.06 = 1.06$$\n\nFor chronic GERD ($i=4$):\n$$\\overline{RR_4} = E[RR_4^{X_4}] = 1 + p_4(RR_4 - 1) = 1 + 0.10(3.5 - 1.0) = 1 + 0.10(2.5) = 1 + 0.25 = 1.25$$\n\nNow, we can find the total average multiplier for the population, $\\overline{RR_{total}}$, by multiplying these individual average multipliers:\n$$\\overline{RR_{total}} = \\overline{RR_1} \\cdot \\overline{RR_2} \\cdot \\overline{RR_3} \\cdot \\overline{RR_4}$$\n$$\\overline{RR_{total}} = 1.49 \\times 1.24 \\times 1.06 \\times 1.25$$\n$$\\overline{RR_{total}} = 1.8476 \\times 1.06 \\times 1.25$$\n$$\\overline{RR_{total}} = 1.958456 \\times 1.25$$\n$$\\overline{RR_{total}} = 2.44807$$\n\nFinally, we compute the total expected incidence $I_{total}$ by multiplying the baseline incidence $I_0$ by this total average multiplier:\n$$I_{total} = I_0 \\cdot \\overline{RR_{total}}$$\n$$I_{total} = (2.0 \\times 10^{-3}) \\times 2.44807$$\n$$I_{total} = 4.89614 \\times 10^{-3}$$\nAs a decimal, this is $0.00489614$. The problem requires the answer to be rounded to four significant figures.\n$$I_{total} \\approx 0.004896$$\nThis is the expected absolute annual incidence of Barrett esophagus in this population, expressed in units of per person-year.",
            "answer": "$$\\boxed{0.004896}$$"
        },
        {
            "introduction": "In clinical practice, arriving at the correct diagnosis requires a careful synthesis of multiple streams of information. This case-based exercise challenges you to act as a pathologist, differentiating Barrett esophagus from one of its key mimics, eosinophilic esophagitis. It highlights the importance of integrating a patient's history, endoscopic findings, and the definitive histologic features to solve a common diagnostic puzzle .",
            "id": "4331328",
            "problem": "A clinician seeks to differentiate Barrett esophagus from eosinophilic esophagitis-associated changes localized to the distal esophagus by integrating clinical and histologic features. The following vignettes describe patients with distal esophageal abnormalities. Which option most strongly supports a diagnosis of Barrett esophagus over eosinophilic esophagitis?\n\nA. A $58$-year-old man with long-standing gastroesophageal reflux disease (GERD) characterized by nocturnal heartburn and regurgitation, central obesity, and no personal history of atopy. Endoscopy reveals salmon-colored tongues extending above the gastroesophageal junction (GEJ) in a short segment. Biopsies from the distal esophagus show nonciliated columnar epithelium with abundant goblet cells containing acidic mucin (Alcian blue positive), with mixed chronic inflammation. Eosinophils are rare ($<5$ per high-power field (HPF)), and there are no eosinophilic microabscesses.\n\nB. A $24$-year-old man with dysphagia and a history of asthma and atopic dermatitis who presents with food impaction. Endoscopy shows multiple concentric rings (trachealization), linear furrows, and white exudates throughout the esophagus. Biopsies from proximal, mid, and distal esophagus demonstrate a dense eosinophilic infiltrate ($>30$ eosinophils/HPF) with eosinophil microabscesses, basal zone hyperplasia, and lamina propria fibrosis. There is no intestinal metaplasia with goblet cells.\n\nC. A $45$-year-old woman with heartburn that improves with proton pump inhibitor (PPI) therapy. Endoscopy shows mild erosions near the GEJ without salmon-colored tongues. Biopsies from the distal esophagus reveal squamous epithelium with basal zone hyperplasia and papillary elongation. Eosinophils are present at approximately $10$ per HPF and are confined to the distal esophagus. No goblet cells are identified.\n\nD. A $63$-year-old man with chronic reflux symptoms on PPI therapy. Endoscopy shows patchy erythema limited to the distal esophagus. Biopsies demonstrate columnar epithelium without goblet cells, with a mixed inflammatory infiltrate including eosinophils at $20$ per HPF and focal eosinophil clustering. There is no endoscopic evidence of rings or furrows, and biopsies were not obtained from the proximal esophagus.\n\nChoose the single best option.",
            "solution": "The problem statement asks to identify which of the provided clinical-pathological vignettes most strongly supports a diagnosis of Barrett esophagus over eosinophilic esophagitis. This is a common differential diagnosis in gastroenterology and pathology.\n\nFirst, validation of the problem statement is required.\n\n**Step 1: Extract Givens**\nThe problem presents four distinct patient vignettes (A, B, C, D) and asks which one most strongly supports a diagnosis of Barrett esophagus (BE) over eosinophilic esophagitis (EoE). The givens are the detailed descriptions within each vignette.\n\n- **Vignette A:** A $58$-year-old man with long-standing gastroesophageal reflux disease (GERD), central obesity, and no atopy. Endoscopy shows salmon-colored tongues above the gastroesophageal junction (GEJ). Biopsies show nonciliated columnar epithelium with abundant goblet cells (Alcian blue positive), rare eosinophils ($<5$ per high-power field (HPF)).\n- **Vignette B:** A $24$-year-old man with dysphagia, food impaction, and a history of asthma and atopic dermatitis. Endoscopy shows rings, furrows, and white exudates throughout the esophagus. Biopsies from the entire esophagus show a dense eosinophilic infiltrate ($>30$ eosinophils/HPF) with microabscesses and no intestinal metaplasia.\n- **Vignette C:** A $45$-year-old woman with heartburn improved by proton pump inhibitor (PPI) therapy. Endoscopy shows mild erosions near the GEJ, no salmon-colored tongues. Biopsies show squamous epithelium with reactive changes and eosinophils at approximately $10$ per HPF, confined to the distal esophagus. No goblet cells are identified.\n- **Vignette D:** A $63$-year-old man with chronic reflux on PPIs. Endoscopy shows patchy erythema limited to the distal esophagus. Biopsies show columnar epithelium without goblet cells, with an eosinophil count of $20$ per HPF. No proximal biopsies were taken.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem is firmly rooted in the medical science of gastrointestinal pathology. Barrett esophagus, eosinophilic esophagitis, and GERD are well-established disease entities. The clinical, endoscopic, and histologic features described in each vignette are classic and factually correct representations of these conditions. The diagnostic criteria mentioned (e.g., goblet cells for BE, eosinophil counts for EoE) are consistent with current medical guidelines.\n- **Well-Posed:** The question is well-posed. It asks for the best fit among several options for a specific diagnosis, which is a standard format for evaluating clinical reasoning. A single best answer can be determined by applying established diagnostic criteria.\n- **Objective:** The descriptions are objective, using precise medical terminology and quantitative data (e.g., patient age, eosinophil counts per HPF) without subjective or biased language.\n- **No Flaws Detected:** The problem is not incomplete, contradictory, unrealistic, ill-posed, or trivial. It represents a valid and relevant clinical scenario.\n\n**Step 3: Verdict and Action**\nThe problem statement is **valid**. A solution will be derived by evaluating each option against the established principles of pathology.\n\n### Derivation of the Correct Answer\n\nThe core of the problem is the differential diagnosis between Barrett esophagus (BE) and eosinophilic esophagitis (EoE).\n\n**Fundamental Principles:**\n1.  **Barrett Esophagus (BE):** The definitive diagnosis of BE requires histologic evidence of intestinal metaplasia in the esophagus. Intestinal metaplasia is defined by the replacement of the normal stratified squamous epithelium with columnar epithelium containing **goblet cells**. Goblet cells are specialized cells that produce mucin, which can be highlighted with special stains like Alcian blue. BE is a known complication of chronic GERD and is a risk factor for esophageal adenocarcinoma. Key supporting features include a clinical history of long-standing GERD, older male patient, obesity, and endoscopic findings of \"salmon-colored tongues\" of mucosa extending proximally from the GEJ. Eosinophils are typically not a prominent feature.\n\n2.  **Eosinophilic Esophagitis (EoE):** EoE is an immune/antigen-mediated chronic inflammatory disease. The diagnosis is clinicopathologic. Clinically, it often presents with dysphagia and food impaction, particularly in younger males, and is strongly associated with personal or family history of atopic diseases (asthma, atopic dermatitis, allergic rhinitis). The key histologic criterion is a dense infiltration of eosinophils within the esophageal squamous epithelium, with a consensus threshold of $\\geq 15$ eosinophils per HPF in at least one biopsy. Other histologic features include eosinophilic microabscesses, superficial layering of eosinophils, and basal cell hyperplasia. Endoscopic findings may include circumferential rings, linear furrows, and white exudates. The inflammation often involves the mid and proximal esophagus, not just the distal portion.\n\n3.  **Reflux Esophagitis (GERD-related):** GERD can cause inflammation characterized histologically by basal cell hyperplasia, papillary elongation, and intraepithelial inflammatory cells, including neutrophils and eosinophils. However, the eosinophil count is typically lower than in EoE (usually $<15$/HPF) and the infiltration is generally confined to the distal esophagus. It does not involve intestinal metaplasia unless BE has developed.\n\n### Option-by-Option Analysis\n\n**A. A $58$-year-old man with long-standing gastroesophageal reflux disease (GERD) characterized by nocturnal heartburn and regurgitation, central obesity, and no personal history of atopy. Endoscopy reveals salmon-colored tongues extending above the gastroesophageal junction (GEJ) in a short segment. Biopsies from the distal esophagus show nonciliated columnar epithelium with abundant goblet cells containing acidic mucin (Alcian blue positive), with mixed chronic inflammation. Eosinophils are rare ($<5$ per high-power field (HPF)), and there are no eosinophilic microabscesses.**\n\n- **Analysis:** This vignette describes the classic profile for Barrett esophagus. The patient demographics (age, sex) and risk factors (long-standing GERD, central obesity) are typical. The endoscopic finding of \"salmon-colored tongues\" is the hallmark appearance of BE. Most importantly, the histologic findings are definitive: the presence of columnar epithelium with abundant goblet cells (confirmed with Alcian blue stain) is the pathognomonic feature of intestinal metaplasia, which defines BE. The very low eosinophil count ($<5$/HPF) effectively rules out EoE.\n- **Verdict:** **Correct**. This is a textbook presentation of Barrett esophagus.\n\n**B. A $24$-year-old man with dysphagia and a history of asthma and atopic dermatitis who presents with food impaction. Endoscopy shows multiple concentric rings (trachealization), linear furrows, and white exudates throughout the esophagus. Biopsies from proximal, mid, and distal esophagus demonstrate a dense eosinophilic infiltrate ($>30$ eosinophils/HPF) with eosinophil microabscesses, basal zone hyperplasia, and lamina propria fibrosis. There is no intestinal metaplasia with goblet cells.**\n\n- **Analysis:** This vignette describes the classic profile for eosinophilic esophagitis. The patient demographic (young man), clinical presentation (dysphagia, food impaction), and atopic history are all characteristic of EoE. The endoscopic findings (rings, furrows, exudates) and the histologic findings (dense, diffuse eosinophilia $>30$/HPF with microabscesses) are definitive for EoE. The explicit statement that there is no intestinal metaplasia rules out BE.\n- **Verdict:** **Incorrect**. This case strongly supports a diagnosis of EoE, not BE.\n\n**C. A $45$-year-old woman with heartburn that improves with proton pump inhibitor (PPI) therapy. Endoscopy shows mild erosions near the GEJ without salmon-colored tongues. Biopsies from the distal esophagus reveal squamous epithelium with basal zone hyperplasia and papillary elongation. Eosinophils are present at approximately $10$ per HPF and are confined to the distal esophagus. No goblet cells are identified.**\n\n- **Analysis:** This case is most consistent with reflux esophagitis secondary to GERD. The symptoms are typical of reflux and respond to PPIs. The histologic findings of reactive squamous changes with a mild, distally-predominant eosinophilia ($10$/HPF) are characteristic of GERD-related inflammation. The eosinophil count is below the threshold for EoE, and the disease is localized, arguing against EoE. Critically, the epithelium is squamous and no goblet cells are present, which rules out a diagnosis of BE.\n- **Verdict:** **Incorrect**. This describes reflux esophagitis without metaplasia.\n\n**D. A $63$-year-old man with chronic reflux symptoms on PPI therapy. Endoscopy shows patchy erythema limited to the distal esophagus. Biopsies demonstrate columnar epithelium without goblet cells, with a mixed inflammatory infiltrate including eosinophils at $20$ per HPF and focal eosinophil clustering. There is no endoscopic evidence of rings or furrows, and biopsies were not obtained from the proximal esophagus.**\n\n- **Analysis:** This case is complex but does not support a definitive diagnosis of BE. The key finding is \"columnar epithelium *without* goblet cells.\" By definition, this is not intestinal metaplasia and therefore not Barrett esophagus. It is often termed cardiac-type metaplasia. The eosinophil count of $20$/HPF is significant and meets the histologic threshold for EoE. This could represent a form of esophageal eosinophilia (e.g., PPI-responsive esophageal eosinophilia, now considered on the EoE spectrum) or unusually eosinophil-rich reflux disease. However, without proximal biopsies and a full clinical picture of atopy/dysphagia, a definitive diagnosis is challenging. What is certain is that the absence of goblet cells rules out BE.\n- **Verdict:** **Incorrect**. This case lacks the defining feature of BE (goblet cells) and has features suspicious for an eosinophilic process other than BE.\n\n**Conclusion**\nOption A is the only vignette that provides unequivocal evidence for a diagnosis of Barrett esophagus, meeting all clinical, endoscopic, and pathognomonic histologic criteria. It simultaneously contains features that argue strongly against a diagnosis of eosinophilic esophagitis.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "A diagnosis is not the end of the story; for precancerous conditions like Barrett esophagus, the crucial task is to manage future risk. This problem introduces a powerful tool from statistics, Bayes' theorem, to formalize how clinicians update a patient's prognosis. You will calculate how negative surveillance results quantitatively reduce the estimated risk of progression, illustrating a core principle of evidence-based medicine .",
            "id": "4331297",
            "problem": "A patient with non-dysplastic Barrett esophagus undergoes surveillance endoscopy with systematic biopsies. Based on clinical risk factors, before any testing the clinician estimates that the patient has a probability $p_{0} = 0.10$ of harboring an occult progression-prone histologic state $D$ (for example, low- or high-grade dysplasia not detected clinically) that substantially elevates short-term risk. If $D$ is present, the one-year probability of progression to esophageal adenocarcinoma (EAC) is $r_{D} = 0.08$. If $D$ is absent, the one-year probability of progression to EAC is $r_{\\bar{D}} = 0.002$. The endoscopic biopsy protocol has sensitivity $Se = 0.82$ for detecting $D$ and specificity $Sp = 0.90$ for correctly reporting no dysplasia when $D$ is absent. The patient undergoes two surveillance endoscopies six months apart, and both reports are negative for dysplasia.\n\nAssume that the underlying histologic state $D$ does not change between the two examinations and that the two test results are conditionally independent given the true state. Using only the definitions of conditional probability and Bayes’ theorem, update the individual’s one-year progression risk immediately after the second negative examination by integrating over the posterior uncertainty in $D$.\n\nExpress the final updated one-year progression risk as a decimal (no units), and round your answer to four significant figures.",
            "solution": "The user wants to solve a probability problem related to medical diagnostics.\n\n### Step 1: Extract Givens\n-   Prior probability of harboring state D: $p_0 = P(D) = 0.10$\n-   One-year probability of progression to EAC if D is present: $r_D = P(EAC | D) = 0.08$\n-   One-year probability of progression to EAC if D is absent: $r_{\\bar{D}} = P(EAC | \\bar{D}) = 0.002$\n-   Sensitivity of the biopsy protocol for detecting D: $Se = P(T^+ | D) = 0.82$\n-   Specificity of the biopsy protocol for correctly reporting no dysplasia when D is absent: $Sp = P(T^- | \\bar{D}) = 0.90$\n-   The patient undergoes two surveillance endoscopies.\n-   Both test results are negative.\n-   The underlying histologic state D does not change.\n-   The two test results are conditionally independent given the true state.\n-   The task is to update the one-year progression risk after the second negative examination.\n-   The final answer should be a decimal rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\n-   **Scientifically Grounded**: The problem uses standard concepts from probability theory (Bayes' theorem, conditional probability) and applies them to a realistic medical scenario (cancer surveillance). The values for prevalence, risk, sensitivity, and specificity are plausible for this clinical context. The problem is firmly based on established mathematical and statistical principles.\n-   **Well-Posed**: The problem is clearly stated. All necessary probabilities and conditions are provided. The assumptions (unchanging state, conditional independence) make the problem solvable with a unique, stable, and meaningful solution.\n-   **Objective**: The language is precise and unbiased. It presents a quantitative problem without subjective elements.\n-   **Flaw Check**:\n    1.  *Scientific/Factual Unsoundness*: None. The logic is sound.\n    2.  *Non-Formalizable/Irrelevant*: The problem is highly relevant to pathology and can be formalized mathematically.\n    3.  *Incomplete/Contradictory*: All necessary data is provided. No contradictions.\n    4.  *Unrealistic/Infeasible*: The scenario is realistic. Probabilities are all between 0 and 1.\n    5.  *Ill-Posed/Poorly Structured*: The problem is well-structured for a Bayesian update.\n    6.  *Pseudo-Profound/Trivial*: The problem requires a multi-step application of Bayes' theorem and the law of total probability, which is a non-trivial reasoning challenge.\n    7.  *Outside Scientific Verifiability*: The result is verifiable through standard probability calculations.\n\n### Step 3: Verdict and Action\nThe problem is valid. A detailed solution will be provided.\n\nLet $D$ be the event that the patient has the progression-prone histologic state, and $\\bar{D}$ be the complementary event that the patient does not have this state. Let $EAC$ be the event of progression to esophageal adenocarcinoma within one year. Let $T_1^{-}$ and $T_2^{-}$ be the events of negative results from the first and second surveillance endoscopies, respectively.\n\nThe problem provides the following probabilities:\nThe prior probability of state $D$ is $P(D) = p_0 = 0.10$.\nThe prior probability of state $\\bar{D}$ is $P(\\bar{D}) = 1 - P(D) = 1 - 0.10 = 0.90$.\n\nThe conditional probabilities of progression are:\n$P(EAC | D) = r_D = 0.08$.\n$P(EAC | \\bar{D}) = r_{\\bar{D}} = 0.002$.\n\nThe test characteristics are given by its sensitivity, $Se$, and specificity, $Sp$.\nSensitivity: $Se = P(T^{+} | D) = 0.82$, where $T^{+}$ is a positive test result.\nSpecificity: $Sp = P(T^{-} | \\bar{D}) = 0.90$.\n\nFrom these, we can derive the probabilities of a negative test result ($T^-$) conditional on the true state:\nThe probability of a false negative is $P(T^{-} | D) = 1 - Se = 1 - 0.82 = 0.18$.\nThe probability of a true negative is $P(T^{-} | \\bar{D}) = Sp = 0.90$.\n\nThe objective is to calculate the updated one-year progression risk, which is the conditional probability of $EAC$ given two negative test results, $P(EAC | T_1^{-}, T_2^{-})$.\n\nWe use the law of total probability, conditioning on the unknown state $D$:\n$$P(EAC | T_1^{-}, T_2^{-}) = P(EAC | D, T_1^{-}, T_2^{-})P(D | T_1^{-}, T_2^{-}) + P(EAC | \\bar{D}, T_1^{-}, T_2^{-})P(\\bar{D} | T_1^{-}, T_2^{-})$$\nIt is a standard assumption in such models that, given the true disease state, the risk of progression is independent of the diagnostic test results. Thus, $P(EAC | D, T_1^{-}, T_2^{-}) = P(EAC | D) = r_D$ and $P(EAC | \\bar{D}, T_1^{-}, T_2^{-}) = P(EAC | \\bar{D}) = r_{\\bar{D}}$.\nThe equation for the updated risk becomes:\n$$R_{\\text{updated}} = r_D P(D | T_1^{-}, T_2^{-}) + r_{\\bar{D}} P(\\bar{D} | T_1^{-}, T_2^{-})$$\nThis requires us to find the posterior probabilities of $D$ and $\\bar{D}$ after two negative tests.\n\nWe apply Bayes' theorem to find the posterior probability $P(D | T_1^{-}, T_2^{-})$:\n$$P(D | T_1^{-}, T_2^{-}) = \\frac{P(T_1^{-}, T_2^{-} | D) P(D)}{P(T_1^{-}, T_2^{-})}$$\nThe denominator $P(T_1^{-}, T_2^{-})$ is the marginal probability of observing two negative results, which is expanded using the law of total probability:\n$$P(T_1^{-}, T_2^{-}) = P(T_1^{-}, T_2^{-} | D) P(D) + P(T_1^{-}, T_2^{-} | \\bar{D}) P(\\bar{D})$$\nThe problem states that the two test results are conditionally independent given the true state. This means:\n$P(T_1^{-}, T_2^{-} | D) = P(T_1^{-} | D) P(T_2^{-} | D) = (P(T^{-} | D))^2$\n$P(T_1^{-}, T_2^{-} | \\bar{D}) = P(T_1^{-} | \\bar{D}) P(T_2^{-} | \\bar{D}) = (P(T^{-} | \\bar{D}))^2$\n\nLet's compute the values of these likelihood terms:\n$P(T_1^{-}, T_2^{-} | D) = (0.18)^2 = 0.0324$.\n$P(T_1^{-}, T_2^{-} | \\bar{D}) = (0.90)^2 = 0.81$.\n\nNow, we can calculate the marginal probability $P(T_1^{-}, T_2^{-})$:\n$P(T_1^{-}, T_2^{-}) = (0.0324)(0.10) + (0.81)(0.90) = 0.00324 + 0.729 = 0.73224$.\n\nWith this, we can find the posterior probability of $D$:\n$$P(D | T_1^{-}, T_2^{-}) = \\frac{P(T_1^{-}, T_2^{-} | D) P(D)}{P(T_1^{-}, T_2^{-})} = \\frac{0.0324 \\times 0.10}{0.73224} = \\frac{0.00324}{0.73224}$$\nThe posterior probability of $\\bar{D}$ is $P(\\bar{D} | T_1^{-}, T_2^{-}) = 1 - P(D | T_1^{-}, T_2^{-})$. Alternatively,\n$$P(\\bar{D} | T_1^{-}, T_2^{-}) = \\frac{P(T_1^{-}, T_2^{-} | \\bar{D}) P(\\bar{D})}{P(T_1^{-}, T_2^{-})} = \\frac{0.81 \\times 0.90}{0.73224} = \\frac{0.729}{0.73224}$$\nNow we substitute these posterior probabilities into the equation for the updated risk:\n$$R_{\\text{updated}} = r_D P(D | T_1^{-}, T_2^{-}) + r_{\\bar{D}} P(\\bar{D} | T_1^{-}, T_2^{-})$$\n$$R_{\\text{updated}} = (0.08) \\left( \\frac{0.00324}{0.73224} \\right) + (0.002) \\left( \\frac{0.729}{0.73224} \\right)$$\n$$R_{\\text{updated}} = \\frac{(0.08)(0.00324) + (0.002)(0.729)}{0.73224}$$\n$$R_{\\text{updated}} = \\frac{0.0002592 + 0.001458}{0.73224}$$\n$$R_{\\text{updated}} = \\frac{0.0017172}{0.73224}$$\n$$R_{\\text{updated}} \\approx 0.002345155...$$\nThe problem requires the answer to be rounded to four significant figures.\nThe first four significant figures are $2$, $3$, $4$, and $5$. The fifth significant figure is $1$, so we round down.\n$$R_{\\text{updated}} \\approx 0.002345$$",
            "answer": "$$\\boxed{0.002345}$$"
        }
    ]
}